Respiratory Syncytial Virus, or RSV, has dominated headlines with an influx of cases across the country and here in Western ...

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory ...

ST. PAUL — Statewide data released Thursday, Jan. 23, by the Minnesota Department of Health indicates that hospitalizations ...

Proportion of positive cases for human metapneumovirus (HMPV) hit a record high for the winter season so far, according to ...

Learn more about whether Twist Bioscience Corporation or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Recent viral outbreaks such as hMPV highlight the need for routine surveillance effective risk communication and boosting healthcare infrastructure Acute respiratory infections are a serious public he ...

This is just a sampling of medical advancements in 2024 chosen for their common presence in the American population. It is ...

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...